Drugs for discoid lupus erythematosus (Q24240456)

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

Management of antimalarial-refractory cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

Chloroquine diphosphate in treatment of discoid lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

Clofazimine in the treatment of discoid lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

Fluocinolone acetonide 0.2 per cent cream--a co-operative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

Thalidomide therapy. An open trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

CHLOROQUINE. A REVIEW OF REACTIONS AND DERMATOLOGIC INDICATIONS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

Phenytoin in the treatment of discoid lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

Isotretinoin for refractory lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

Efalizumab in the treatment of discoid lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

Quinacrine hydrochloride (atabrine) in the treatment of lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021

Discoid lupus erythematosus. Is systemic treatment necessary?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021

Efficiency of acitretin in the treatment of cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021

Discoid lupus erythematosus: successful treatment with oral methotrexate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021

Amodiaquine hydrochloride in the treatment of chronic discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021

Low-dose intralesional interferon alfa for discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021

CHRONIC DISCOID LUPUS ERYTHEMATOSUS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021

Intralesional triamcinolone as an adjunct to antimalarial drugs in the treatment of chronic discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021

Treatment of chronic discoid lupus erythematosus with fluocinolone acetonide ointment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021

Dapsone and discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021

Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021

Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021

Efficacy of sulfasalazine in discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021

Dapsone in the treatment of cutaneous lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021

Treatment of discoid lupus erythematosus with betametasone-valerate cream 1 percent.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002954.PUB2

7 January 2021